"Is Winter Coming to AI in pharma?" industry benchmark opinions from OKRA, Biofourmis and Novartis.
Should artificial intelligence be a technology we embrace in uncertain times? Or reject? Recently our CEO, Loubna Bouarfa, sat down with Paul Simms to address this very question.
"Working with OKRA to co-develop tools for our field teams has been really satisfying, it has been like working with a trusted partner, open and honest discussion and ability to challenge each other leading to a product that met, and surpassed expectation."Neil Copping - Associate Director Data and Field Team Design - BMS
"OKRA is the only AI company in my experience to have delivered tangible value to the pharma industry."Sreeram Ramagopalan - Global Head Real World Data, Roche
"The team is superb, very collaborative and willing to flex their approach to meet our needs. OKRA helped us to uncover actionable insights."Ahmed Sidat - Head of Digital and Multichannel - Janssen Pharmaceuticals
"In my view, OKRA can help take Pharma to a new level when it comes to truly benefitting from AI in their commercial practices, and it helps that they’re a great team to work with too!"Colin Williams - Global Product Lead, Veeva Rep Channels, GSK
The Covid-19 virus and the subsequent lockdown has been the catalyst for the long-awaited digital transformation of the Pharmaceutical industry, forcing an unprecedented shift in the way we communicate with key stakeholders.
Do you want to learn more?
Leave your email here and we will contact you.
For any other requests including press and speaking opportunities, please email firstname.lastname@example.org